News in Brief: Australian leaders head to Bangkok; BLS appoints Angus Walker as alternate director by Adam Sheldon September 14, 2026September 17, 2026 Senior Australian health officials and executives from some of the country’s leading firms will be among […]
BLS sees potential FY27 ‘upside’ as UK facility nears launch by Adam Sheldon September 8, 2026September 9, 2026
BLS triples profit, tips revenue to grow up to 55% in FY27 by Adam Sheldon August 31, 2026August 31, 2026
‘This is just the beginning’: BLS CEO on German expansion and vision for firm by Adam Sheldon August 6, 2026August 6, 2026
BLS hits top end of guidance after strong final quarter of FY26 by Steve Jones July 27, 2026July 28, 2026
News in brief: Legalise Cannabis Victoria seeks $10,000; Bioxyne confirms BLS rebrand by Adam Sheldon June 29, 2026July 2, 2026
Bioxyne to be renamed as BLS Pharmaceuticals to ‘reduce brand confusion’ by Adam Sheldon June 23, 2026June 25, 2026
